Inherited Metabolic Disorders: Types and Symptoms

Inherited metabolic disorders are genetic conditions that affect the body’s ability to process certain nutrients. Here are some common types and their symptoms:

Phenylketonuria (PKU): This autosomal recessive condition affects amino acid metabolism. It causes a deficiency of the enzyme phenylalanine hydroxylase, which can lead to behavioural problems, seizures, and learning disability. PKU is screened for with the newborn heel prick test.

G6PD deficiency: This X-linked recessive condition predisposes those affected to develop haemolysis. It does not affect amino acid metabolism. Patients are usually asymptomatic unless they have a haemolytic crisis triggered by an infection or certain medications.

Lesch–Nyhan syndrome: This X-linked condition affects uric acid metabolism and causes hyperuricaemia. It does not affect amino acid metabolism. Affected males have severe developmental delay, behavioural and cognitive dysfunction, and marked involuntary movements. They also develop recurrent self-mutilation habits.

Medium chain acyl-CoA dehydrogenase deficiency (MCADD): This autosomal recessive condition affects fatty acid oxidation. It does not affect amino acid metabolism. Babies with MCADD usually present with lethargy, poor feeding, and vomiting. It is screened for with the newborn heel prick test.

Porphyria: This is a deficiency of enzymes that affect haem synthesis. It can lead to acute porphyria (abdominal pain, psychiatric symptoms, breathing problems) or cutaneous porphyria.

Bone Metastases: Common Tumours, Symptoms, and Diagnosis

Bone metastases are a common occurrence in patients with malignant disease, affecting approximately 30% of cases. The most frequent tumours that cause bone metastases are breast, prostate, bronchus, kidney, and thyroid, with breast and prostate cancers accounting for the majority. Symptoms of bone metastases typically include bone pain, the presence of a lump, pathological fractures, hypercalcaemia, or cord compression. Pathological fractures occur in about 10% of patients with bone metastases. Radiological changes usually occur late, and bone scintigraphy is the most sensitive diagnostic tool available to detect metastatic spread. Most metastases are osteolytic, but some tumours, such as prostate carcinoma, cause osteosclerotic lesions.

Understanding Post-Traumatic Stress Disorder (PTSD)

Post-traumatic stress disorder (PTSD) is a mental health condition that can develop in individuals of any age following a traumatic event. This can include experiences such as natural disasters, accidents, or even childhood abuse. PTSD is characterized by a range of symptoms, including re-experiencing the traumatic event through flashbacks or nightmares, avoidance of situations or people associated with the event, hyperarousal, emotional numbing, depression, and even substance abuse.

Effective management of PTSD involves a range of interventions, depending on the severity of the symptoms. Single-session interventions are not recommended, and watchful waiting may be used for mild symptoms lasting less than four weeks. Military personnel have access to treatment provided by the armed forces, while trauma-focused cognitive behavioral therapy (CBT) or eye movement desensitization and reprocessing (EMDR) therapy may be used in more severe cases.

It is important to note that drug treatments for PTSD should not be used as a routine first-line treatment for adults. If drug treatment is used, venlafaxine or a selective serotonin reuptake inhibitor (SSRI), such as sertraline, should be tried. In severe cases, NICE recommends that risperidone may be used. Overall, understanding the symptoms and effective management of PTSD is crucial in supporting individuals who have experienced traumatic events.

Alendronic acid is a bisphosphonate that can cause various oesophageal problems, including oesophagitis and ulceration. It is commonly used to treat and prevent osteoporosis. Other side effects of bisphosphonates include fever, myalgia, arthralgia, and hypocalcaemia. In this case, the patient has developed oesophageal ulceration, which is a common side effect of alendronic acid. Treatment may involve high-dose PPI and discontinuation of the medication.

Amlodipine is not the correct answer. It is a calcium channel blocker used to treat angina and hypertension. While it can cause dyspepsia, it does not typically cause gastrointestinal ulceration. Some studies have even suggested that amlodipine may have a protective effect. Common side effects of amlodipine include constipation, lower limb oedema, and headache.

Aspirin is also not the correct answer. While aspirin and other NSAIDs are associated with peptic ulcer disease, there is no evidence to suggest that they cause oesophageal ulcers.

Ibuprofen is also not the correct answer. It is a commonly used NSAID that can cause gastric irritation and peptic ulcers with prolonged use. However, oesophageal ulcers are rare and are more likely to be caused by alendronic acid.

Bisphosphonates: Uses and Adverse Effects

Bisphosphonates are drugs that mimic the action of pyrophosphate, a molecule that helps prevent bone demineralization. They work by inhibiting osteoclasts, which are cells that break down bone tissue. This reduces the risk of bone fractures and can be used to treat conditions such as osteoporosis, hypercalcemia, Paget’s disease, and pain from bone metastases.

However, bisphosphonates can have adverse effects, including oesophageal reactions such as oesophagitis and ulcers, osteonecrosis of the jaw, and an increased risk of atypical stress fractures of the proximal femoral shaft in patients taking alendronate. Patients may also experience an acute phase response, which can cause fever, myalgia, and arthralgia. Hypocalcemia, or low calcium levels, can also occur due to reduced calcium efflux from bone, but this is usually not clinically significant.

To minimize the risk of adverse effects, patients taking oral bisphosphonates should swallow the tablets whole with plenty of water while sitting or standing. They should take the medication on an empty stomach at least 30 minutes before breakfast or other oral medications and remain upright for at least 30 minutes after taking the tablet. Hypocalcemia and vitamin D deficiency should be corrected before starting bisphosphonate treatment, and calcium supplements should only be prescribed if dietary intake is inadequate. The duration of bisphosphonate treatment varies depending on the patient’s level of risk, and some authorities recommend stopping treatment after five years for low-risk patients with a femoral neck T-score of > -2.5.

Anaphylactoid reactions caused by N-acetylcysteine are not IgE mediated but result from the direct activation of mast cells and/or basophils, as well as the activation of the complement and/or bradykinin cascade. These reactions can lead to severe symptoms, including airway involvement, cardiovascular collapse, and even death, which are similar to anaphylaxis. In contrast, anaphylaxis is less common and is IgE mediated. IgA deficiency does not cause drug reactions but can increase the risk of anaphylaxis. Type III hypersensitivity disorders, characterized by IgM and IgG immune complex formation, are not associated with acute drug reactions.

Paracetamol overdose management guidelines were reviewed by the Commission on Human Medicines in 2012. The new guidelines removed the ‘high-risk’ treatment line on the normogram, meaning that all patients are treated the same regardless of their risk factors for hepatotoxicity. However, for situations outside of the normal parameters, it is recommended to consult the National Poisons Information Service/TOXBASE. Patients who present within an hour of overdose may benefit from activated charcoal to reduce drug absorption. Acetylcysteine should be given if the plasma paracetamol concentration is on or above a single treatment line joining points of 100 mg/L at 4 hours and 15 mg/L at 15 hours, regardless of risk factors of hepatotoxicity. Acetylcysteine is now infused over 1 hour to reduce adverse effects. Anaphylactoid reactions to IV acetylcysteine are generally treated by stopping the infusion, then restarting at a slower rate. The King’s College Hospital criteria for liver transplantation in paracetamol liver failure include arterial pH < 7.3, prothrombin time > 100 seconds, creatinine > 300 µmol/l, and grade III or IV encephalopathy.

The Shoulder Joint: Flexible and Unstable

The shoulder joint is known for its remarkable flexibility, allowing for a wide range of motion. This is due to the small area of contact between the upper arm bone and the socket on the scapula, which is also shallow. However, this same feature also makes the shoulder joint unstable, making it the most susceptible to dislocation.

In summary, the shoulder joint flexibility is due to its small contact area and shallow socket, but this also makes it unstable and prone to dislocation.

Understanding Serotonin Syndrome

Serotonin syndrome is a potentially life-threatening condition caused by an excess of serotonin in the body. It can be triggered by a variety of medications and substances, including monoamine oxidase inhibitors, SSRIs, St John’s Wort, tramadol, ecstasy, and amphetamines. The condition is characterized by neuromuscular excitation, hyperreflexia, myoclonus, rigidity, autonomic nervous system excitation, hyperthermia, sweating, and altered mental state, including confusion.

Management of serotonin syndrome is primarily supportive, with IV fluids and benzodiazepines used to manage symptoms. In more severe cases, serotonin antagonists such as cyproheptadine and chlorpromazine may be used. It is important to note that serotonin syndrome can be easily confused with neuroleptic malignant syndrome, which has similar symptoms but is caused by a different mechanism. Both conditions can cause a raised creatine kinase (CK), but it tends to be more associated with NMS. Understanding the causes, features, and management of serotonin syndrome is crucial for healthcare professionals to ensure prompt and effective treatment.

Patients who have a history of chronic alcohol intake, anorexia nervosa, or are taking liver-enzyme inducing drugs such as rifampicin, phenytoin or carbamazepine are at high risk of hepatotoxicity if they overdose on paracetamol. This can cause permanent damage to the liver and even lead to mortality. Acute alcohol intake, on the other hand, is not a risk factor for hepatotoxicity and may even be protective. Aspirin can harm the stomach lining and kidneys if taken too frequently, but it is unlikely to have a lasting effect on the liver. Statin use does not increase the risk of hepatotoxicity. While an AST level of 110 iu/l indicates acute hepatocyte damage, it does not provide information on the long-term effects on the liver, which can be better assessed using Prothrombin time or albumin.

Risk Factors for Paracetamol Overdose

Paracetamol overdose can lead to hepatotoxicity, especially in certain groups of patients. Those taking liver enzyme-inducing drugs such as rifampicin, phenytoin, carbamazepine, or those with chronic alcohol excess or who take St John’s Wort are at an increased risk. Malnourished patients, such as those with anorexia nervosa, or those who have not eaten for a few days are also at a higher risk. Interestingly, acute alcohol intake does not increase the risk of hepatotoxicity, and may even have a protective effect. It is important for healthcare providers to be aware of these risk factors when treating patients who have overdosed on paracetamol.

Understanding Risk Factors for Post-Operative Nausea and Vomiting (PONV)

Post-operative nausea and vomiting (PONV) is a common complication following surgery that can cause discomfort and delay recovery. Several risk factors have been identified, including a history of PONV or motion sickness, post-operative opioid use, non-smoking, and female sex. General anesthesia, longer duration of anesthesia, and certain types of surgery also increase the risk of PONV. Interestingly, younger age is associated with a greater risk of PONV, while pre-operative hospital stay does not appear to be a risk factor. While it was once thought that intraoperative oxygen might protect against PONV, recent studies have suggested otherwise. Understanding these risk factors can help healthcare providers identify patients who may benefit from preventative measures to reduce the incidence of PONV.

Based on the symptoms of tinnitus, anxiety, and diaphoresis, it is probable that the patient has overdosed on salicylates. Salicylate overdoses usually manifest with respiratory alkalosis at first, caused by hyperventilation, and then metabolic acidosis due to the buildup of lactic acid. Therefore, although options 1 and 3 are feasible, option 4 is the most probable.

Salicylate overdose can result in a combination of respiratory alkalosis and metabolic acidosis. The initial effect of salicylates is to stimulate the respiratory center, leading to hyperventilation and respiratory alkalosis. However, as the overdose progresses, the direct acid effects of salicylates, combined with acute renal failure, can cause metabolic acidosis. In children, metabolic acidosis tends to be more prominent. Other symptoms of salicylate overdose include tinnitus, lethargy, sweating, pyrexia, nausea/vomiting, hyperglycemia and hypoglycemia, seizures, and coma.

The treatment for salicylate overdose involves general measures such as airway, breathing, and circulation support, as well as administering activated charcoal. Urinary alkalinization with intravenous sodium bicarbonate can help eliminate aspirin in the urine. In severe cases, hemodialysis may be necessary. Indications for hemodialysis include a serum concentration of salicylates greater than 700 mg/L, metabolic acidosis that is resistant to treatment, acute renal failure, pulmonary edema, seizures, and coma.

It is important to note that salicylates can cause the uncoupling of oxidative phosphorylation, which leads to decreased adenosine triphosphate production, increased oxygen consumption, and increased carbon dioxide and heat production. Therefore, prompt and appropriate treatment is crucial in managing salicylate overdose.